Sarepta rebounds on data for limb-girdle muscular dystrophy gene therapyShares in Sarepta spiked on positive data for its gene therapy for a form of muscular dystrophy, after Share XSarepta rebounds on data for limb-girdle muscular dystrophy gene therapyhttps://pharmaphorum.com/news/sarepta-rebounds-on-data-for-limb-girdle-muscular-dystrophy-gene-therapy/
Understanding muscular dystrophyChris Anselmo, who has a rare form of muscular dystrophy, hopes to educate pharma on the patient journey Share XUnderstanding muscular dystrophyhttps://pharmaphorum.com/views-analysis-patients/understanding-muscular-dystrophy/
